Lacosamide 11014-0670
Product NDC
11014-0670- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule, Extended Release
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CV
- Marketing Start
- February 29, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 200 mg/1 |
Packaging Options(1)
12 BOTTLE in 1 BOX (11014-0670-1) / 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE